A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid 20 mg vs. Losec 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy.

Trial Profile

A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid 20 mg vs. Losec 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jan 2013

At a glance

  • Drugs Omeprazole (Primary) ; Omeprazole/sodium bicarbonate (Primary)
  • Indications Gastro-oesophageal reflux; Heartburn
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top